These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27071766)

  • 1. Semi-synthesis of a tag-free O-GlcNAcylated tau protein by sequential chemoselective ligation.
    Schwagerus S; Reimann O; Despres C; Smet-Nocca C; Hackenberger CP
    J Pept Sci; 2016 May; 22(5):327-33. PubMed ID: 27071766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tag-Free Semi-Synthesis of the Tau Protein.
    Reimann O; Smet-Nocca C; Hackenberger CP
    Methods Mol Biol; 2017; 1523():215-235. PubMed ID: 27975252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traceless purification and desulfurization of tau protein ligation products.
    Reimann O; Smet-Nocca C; Hackenberger CP
    Angew Chem Int Ed Engl; 2015 Jan; 54(1):306-10. PubMed ID: 25404175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau.
    Yu CH; Si T; Wu WH; Hu J; Du JT; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Oct; 375(1):59-62. PubMed ID: 18671940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
    Yuzwa SA; Vocadlo DJ
    Methods Mol Biol; 2017; 1523():237-248. PubMed ID: 27975253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
    Cameron A; Giacomozzi B; Joyce J; Gray A; Graham D; Ousson S; Neny M; Beher D; Carlson G; O'Moore J; Shearman M; Hering H
    FEBS Lett; 2013 Nov; 587(22):3722-8. PubMed ID: 24113653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native chemical ligation between asparagine and valine: application and limitations for the synthesis of tri-phosphorylated C-terminal tau.
    Reimann O; Glanz M; Hackenberger CP
    Bioorg Med Chem; 2015 Jun; 23(12):2890-4. PubMed ID: 25882528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine/Threonine Ligation: Origin, Mechanistic Aspects, and Applications.
    Liu H; Li X
    Acc Chem Res; 2018 Jul; 51(7):1643-1655. PubMed ID: 29979577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine.
    Arnold CS; Johnson GV; Cole RN; Dong DL; Lee M; Hart GW
    J Biol Chem; 1996 Nov; 271(46):28741-4. PubMed ID: 8910513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine- versus serine-phosphorylation leads to conformational changes in a synthetic tau peptide.
    Fabian H; Otvos L; Szendrei GI; Lang E; Mantsch HH
    J Biomol Struct Dyn; 1994 Dec; 12(3):573-9. PubMed ID: 7537044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
    Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
    J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc modification in diabetes and Alzheimer's disease.
    Dias WB; Hart GW
    Mol Biosyst; 2007 Nov; 3(11):766-72. PubMed ID: 17940659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Synthesis and Biological Applications of O-GlcNAcylated Peptides and Proteins.
    Groenevelt JM; Corey DJ; Fehl C
    Chembiochem; 2021 Jun; 22(11):1854-1870. PubMed ID: 33450137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.
    Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T
    Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Synthesis of Microtubule-Associated Protein Tau.
    Powell WC; Jing R; Walczak MA
    J Am Chem Soc; 2023 Oct; 145(39):21514-21526. PubMed ID: 37737824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.
    Wang YP; Biernat J; Pickhardt M; Mandelkow E; Mandelkow EM
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10252-7. PubMed ID: 17535890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.